Alexander Buckenham Boyle1, Mark Zhu2, Chris Frampton3, Vaughan Poutawera2, Andrew Vane2. 1. Department of Orthopaedic Surgery, Tauranga Hospital, Private Bag 12024, Tauranga, 3143, New Zealand. alexander.boyle@bopdhb.govt.nz. 2. Department of Orthopaedic Surgery, Tauranga Hospital, Private Bag 12024, Tauranga, 3143, New Zealand. 3. Department of Medicine, The University of Otago, Christchurch, New Zealand.
Abstract
BACKGROUND: Multiple joint registries have reported better implant survival for patients aged > 75 years undergoing total hip arthroplasty (THA) with cemented implant combinations when compared to hybrid or uncemented implant combinations. However, there is considerable variation within these broad implant categories, and it has therefore been suggested that specific implant combinations should be compared. We analysed the most common contemporary uncemented (Corail/Pinnacle), hybrid (Exeter V40/Trident) and cemented (Exeter V40/Exeter X3) implant combinations in the New Zealand Joint Registry (NZJR) for patients aged > 75 years. METHODS: All THAs performed using the selected implants in the NZJR for patients aged > 75 years between 1999 and 2018 were included. Demographic data, implant type, and outcome data including implant survival, reason for revision, and post-operative Oxford Hip Scores were obtained from the NZJR, and detailed survival analyses were performed. Primary outcome was revision for any reason. Reason for revision, including femoral or acetabular failure, and time to revision were recorded. RESULTS: 5427 THAs were included. There were 1105 implantations in the uncemented implant combination group, 3040 in the hybrid implant combination group and 1282 in the cemented implant combination group. Patient reported outcomes were comparable across all groups. Revision rates were comparable between the cemented implant combination (0.31 revisions/100 component years) and the hybrid implant combination (0.40 revisions/100 component years) but were statistically significantly higher in the uncemented implant combination (0.80/100 component years). Femoral-sided revisions were significantly greater in the uncemented implant combination group. CONCLUSION: The cemented implant and hybrid implant combinations provide equivalent survival and functional outcomes in patients aged over 75 years. Caution is advised if considering use of the uncemented implant combination in this age group, predominantly due to a higher risk of femoral-sided revisions. The authors recommend comparison of individual implants rather than broad categories of implants.
BACKGROUND: Multiple joint registries have reported better implant survival for patients aged > 75 years undergoing total hip arthroplasty (THA) with cemented implant combinations when compared to hybrid or uncemented implant combinations. However, there is considerable variation within these broad implant categories, and it has therefore been suggested that specific implant combinations should be compared. We analysed the most common contemporary uncemented (Corail/Pinnacle), hybrid (Exeter V40/Trident) and cemented (Exeter V40/Exeter X3) implant combinations in the New Zealand Joint Registry (NZJR) for patients aged > 75 years. METHODS: All THAs performed using the selected implants in the NZJR for patients aged > 75 years between 1999 and 2018 were included. Demographic data, implant type, and outcome data including implant survival, reason for revision, and post-operative Oxford Hip Scores were obtained from the NZJR, and detailed survival analyses were performed. Primary outcome was revision for any reason. Reason for revision, including femoral or acetabular failure, and time to revision were recorded. RESULTS: 5427 THAs were included. There were 1105 implantations in the uncemented implant combination group, 3040 in the hybrid implant combination group and 1282 in the cemented implant combination group. Patient reported outcomes were comparable across all groups. Revision rates were comparable between the cemented implant combination (0.31 revisions/100 component years) and the hybrid implant combination (0.40 revisions/100 component years) but were statistically significantly higher in the uncemented implant combination (0.80/100 component years). Femoral-sided revisions were significantly greater in the uncemented implant combination group. CONCLUSION: The cemented implant and hybrid implant combinations provide equivalent survival and functional outcomes in patients aged over 75 years. Caution is advised if considering use of the uncemented implant combination in this age group, predominantly due to a higher risk of femoral-sided revisions. The authors recommend comparison of individual implants rather than broad categories of implants.
Authors: Kristoff Corten; Robert B Bourne; Kory D Charron; Keegan Au; Cecil H Rorabeck Journal: Clin Orthop Relat Res Date: 2010-07-13 Impact factor: 4.176
Authors: Keith R Berend; Adolph V Lombardi; Thomas H Mallory; Kathie L Dodds; Joanne B Adams Journal: J Arthroplasty Date: 2004-04 Impact factor: 4.757
Authors: Vera Halvorsen; Anne Marie Fenstad; Lars B Engesæter; Lars Nordsletten; Søren Overgaard; Alma B Pedersen; Johan Kärrholm; Maziar Mohaddes; Antti Eskelinen; Keijo T Mäkelä; Stephan M Röhrl Journal: Acta Orthop Date: 2019-05-15 Impact factor: 3.717